Previous Close | 0.3166 |
Open | 0.3190 |
Bid | 0.2260 x 200 |
Ask | 0.4095 x 200 |
Day's Range | 0.3100 - 0.3338 |
52 Week Range | 0.2810 - 3.2100 |
Volume | |
Avg. Volume | 5,060,754 |
Market Cap | 2.028M |
Beta (5Y Monthly) | 2.50 |
PE Ratio (TTM) | 0.03 |
EPS (TTM) | 11.8500 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
SAN FRANCISCO, August 14, 2024--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its second quarter 2024 financial results and discussed growth strategies based on its investments in vagus nerve stimulation ("VNS").
SAN FRANCISCO, August 06, 2024--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will report its Q2 2024 financial results and a corporate update via pre-recorded conference call and webcast on Wednesday, August 14 at 1:30 PM PT / 4:30 PM ET. Current shareholders, interested individuals and future investors are encouraged to join the webcast to hear the company executives provide a c
SAN FRANCISCO, August 02, 2024--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the Virtual Annual General Meeting of Shareholders will be held on Friday, August 9, 2024 at 10:00 a.m., Pacific Time. The Company has adopted a virtual format for our Annual Meeting to provide a healthy, consistent, and convenient experience for all stockholders regardless of location.